Effect of a third booster dose of COVID-19 mRNA vaccine in patients with haematological cancer after the initial two-dose vaccination - a single centre report
<p>Novel Coronavirus SARS-CoV-2 causing COVID-19 has been subject to intensive interest since its appearance in 2019, with the risk of severe course being significantly higher for adult patients with hematological malignancy. Results on a two-dose, standard vaccination regimen in patients with...
Saved in:
Main Authors: | Šušol Ondrej (Author), Šušolová Barbora (Author), Hájek Roman (Author) |
---|---|
Format: | Book |
Published: |
Journal of Vaccines and Immunology - Peertechz Publications,
2022-08-08.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
by: Abdulbaril Olagunju MD, et al.
Published: (2022) -
A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
by: Frances Priddy, et al.
Published: (2024) -
Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine
by: Viravarn Luvira, et al.
Published: (2024) -
Side Effects after mRNA COVID-19 Vaccine as a Booster in Health Workers
by: Temmasonge Radi Pakki, et al.
Published: (2022) -
Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape
by: Rituparna Das, et al.
Published: (2023)